At this year’s EUVC Summit Awards, the “Exit of the Year” category drew intense debate—and for good reason.
Europe is finally entering its outcome era, and this year brought no shortage of competitive contenders.
But one exit stood out.
Winner: SV Health Investors, for the exit of EyeBio
As the host reminded us, this award isn’t just about a number on a term sheet:
“With exits, we’re celebrating outcomes. Outcomes that validate years of work, conviction, and follow-through.”
For SV Health, this exit marked a textbook example of deep science meets disciplined execution.
It wasn’t a flash-in-the-pan. It was a story of patient capital, strategic support, and a global-scale outcome born in Europe.
A breakthrough healthtech company delivering real-world impact
An outcome that unlocked returns and credibility
A case study in what’s possible when bio meets business in the right way
In a space where timelines are long and conviction is everything, SV Health and EyeBio proved what Europe is capable of when the pieces align.
“Hopefully, we’ll be seeing more and more exits like this in the years ahead.”
We agree. Because one great exit isn’t just a win for the team—it’s a signal to the ecosystem.
It tells LPs, policymakers, founders, and future fund managers: we can build here, and we can win here.
Congratulations to SV Health Investors and the entire EyeBio team.
Let’s keep building toward the next one.
Celebrating More Than Just ReturnsWhy It MatteredThe Bar Has Been Raised
